Increased levels of circulating endothelial progenitor cells in patients with moyamoya disease

Stroke

Volumn 40, Issue 2, 2009, Pages 432-438

  Rafat, Neysan ^a   Beck, Grietje Ch ^a   Peña Tapia, Pablo G ^b   Schmiedek, Peter ^b   Vajkoczy, Peter ^c  

^a Department of Anaesthesiology and Critical Care Medicine ^*  (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cerebral revascularization; Circulating endothelial progenitor cells; Moyamoya disease; Vascular endothelial growth factor

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VASCULOTROPIN C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 8; VASCULOTROPIN A;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CELL MOTILITY; CEREBROVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY GRADIENT CENTRIFUGATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MOYAMOYA DISEASE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; STEM CELL; BIOSYNTHESIS; BRAIN ARTERY; BRAIN ATHEROSCLEROSIS; CEREBRAL REVASCULARIZATION; ERYTHROID PRECURSOR CELL; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

ADOLESCENT; ADULT; AGED; CENTRIFUGATION, DENSITY GRADIENT; CEREBRAL ARTERIES; CEREBRAL REVASCULARIZATION; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROID PRECURSOR CELLS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; MOYAMOYA DISEASE; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 60549107468     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.529420     Document Type: Article

References (46)

1. Horn P, Vajkoczy P, Schmiedek P. Diagnosis and treatment of Moya-moya disease. Nervenarzt. 2001;72:406-415.
2. Lim M, Cheshier S, Steinberg GK. New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moya-moya. Curr Neurovasc Res. 2006;3:237-245.
3. Yoshimoto T, Houkin K, Takahashi A, Abe H. Angiogenic factors in Moyamoya disease. Stroke.l996;27:2160-2165.
4. Czabanka M, Peña-Tapia P, Schubert GA, Woitzik J, Vajkoczy P, Schmiedek P. Characterization of Cortical Microvascularization in Adult Moyamoya Disease. Stroke. 2008;Apr 10:[Epub ahead of print].
5. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967.
6. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221-228.
7. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA. 2000;97:3422-3427.
8. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularisation and regeneration. Nat Med. 2003;9:702-712.
9. Hristov M, Weber C. Endothelial progenitor cells:Characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med. 2004;8:498-508.
10. Tamion F, Le Cam-Duchez V, Menard JF, Girault C, Coquerel A, Bon-marchand G. Erythropoietin and renin as biological markers in critically ill patients. Crit Care. 2004;8:R328-R335.
11. Kalka C, Asahara T, Krone W, Isner JM. Angiogenesis and vasculo-genesis. Therapeutic strategies for stimulation of postnatal neovascularization. Hen. 2000;25:611-622.
12. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, Dimmeler S. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood. 2003;102:1340-1346.
13. Powell TM, Paul JD, Hill JM, Thompson M, Benjamin M, Rodrigo M, McCoy JP, Read EJ, Khuu HM, Leitman SF, Finkel T, Cannon RO III. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2005;25:296-301.
14. Grad S, Ertel W, Keel M, Infanger M, Vonderschmitt DJ, Maly FE. Strongly enhanced serum levels of vascular endothelial growth factor (VEGF) after polytrauma and burn. Clin Chem Lab Med. 1998;36:379-383
15. Horn P, Vajkoczy P, Thome C, Muench E, Schilling L, Schmiedek P. Xenon-induced flow activation in patients with cerebral insult who undergo xenon-enhanced CT blood flow studies. AJNR Am J Neuroradiol. 2001;22:1543-1549.
16. Rafat N, Hanusch C, Brinkkoetter PT, Schulte J, Brade J, Zijlstra JG, van der Woude FJ, van Ackern K, Yard BA, Beck GC. Increased circulating endothelial progenitor cells in septic patients:Correlation with survival. Crit Care Med. 2007;35:1677-1684.
17. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rütten H, Fichtlscherer S, Martin H, Zeiher AM. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-ki-nase/Akt pathway. J Clin Invest. 2001;108:391-397.
18. Yoshihara T, Taguchi A, Matsuyama T, Shimizu Y, Kikuchi-Taura A, Soma T, Stern DM, Yoshikawa H, Kasahara Y, Moriwaki H, Nagatsuka K, Naritomi H. Increase in circulating CD34-positive cells in patients with angiographic evidence of Moyamoya-like vessels. J Cereb Blood Flow Metab. 2008;Jan 30:[Epub ahead of print]
19. Khan SS, Solomon MA, McCoy JP. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom. 2005;64:1-8.
20. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593-600.
21. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95:952-958.
22. Burnham EL, Taylor WR, Quyyumi AA, Rojas M, Brigham KL, Moss M. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med. 2005;172:854-860.
23. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999-1007.
24. Shantsila E, Watson T, Tse HF, Lip GYH. Endothelial colony forming units:Are they a reliable marker of endothelial progenitor cell numbers? Ann Med. 2007;39:474-479.
25. Urbich C, Dimmeler S. Endothelial progenitor cells:Characterization and role in vascular biology. Circ Res. 2004;95:343-353.
26. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularisation by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 1999;18:3964-3972.
27. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM, Dimmeler S. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol. 2005;39:733-742.
28. Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension. 2005;45:321-325.
29. Cao Y, Hong A, Schulten H, Post MJ. Update on therapeutic neovascularization. Cardiovasc Res. 2005;65(3):639-48.
30. Jin KL, Mao XO, Nagayama T, Goldsmith PC, Greenberg DA. Induction of vascular endothelial growth factor and hypoxia-inducible factor-1 alpha by global ischemia in rat brain. Neuroscience. 2000;99:577-585.
31. Sakamoto S, Kiura Y, Yamasaki F, Shibukawa M, Ohba S, Shrestha P, Sugiyama K, Kurisu K. Expression of vascular endothelial growth factor in dura mater of patients with Moyamoya disease. Neurosurg Rev. 2008;31:77-81.
32. Hojo M, Hoshimaru M, Miyamoto S, Taki W, Nagata I, Asahi M, Matsuura N, Ishizaki R, Kikuchi H, Hashimoto N. Role of transforming growth factor-betal in the pathogenesis of Moyamoya disease. J Neurosurg. 1998;89:623-629.
33. Kusaka N, Sugiu K, Tokunaga K, Katsumata A, Nishida A, Namba K, Hamada H, Nakashima H, Date I. Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery. J Neurosurg. 2005;103:882-890.
34. Malek AM, Connors S, Robertson RL, Folkman J, Scott RM. Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in Moyamoya and central nervous system disorders. Pediatr Neurosurg. 1997;27:182-189.
35. Takahashi A, Sawamura Y, Houkin K, Kamiyama H, Abe H. The cerebrospinal fluid in patients with Moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor. Neurosci Lett. 1993;160:214-216.
36. Takekawa Y, Umezawa T, Ueno Y, Sawada T, Kobayashi M. Pathological and immunohistochemical findings of an autopsy case of adult Moyamoya disease. Neuropathology. 2004;24:236-242.
37. Yoshimoto T, Houkin K, Takahashi A, Abe H. Evaluation of cytokines in cerebrospinal fluid from patients with Moyamoya disease. Clin Neurol Neurosurg. 1997;99(S2):S218-S220.
38. Hristov M, Fach C, Becker C, Heussen N, Liehn EA, Blindt R, Hanrath P, Weber C. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis. 2007;192:413-420.
39. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-E7.
40. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, Taylor DA. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation. 2003;108:457-463.
41. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol. 2005;45:1441-1448.
42. Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL. The aging of hematopoietic stem cells. Nat Med. 1996;2:1011-1016.
43. Dimmeler S, Vasa-Nicotera M. Aging of progenitor cells:limitation for regenerative capacity? J Am Coll Cardiol. 2003;42:2081-2082.
44. Chang EI, Loh SA, Ceradini DJ, Chang EI, Lin SE, Bastidas N, Aarabi S, Chan DA, Freedman ML, Giaccia AJ, Gurtner GC. Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1 alpha stabilization during ischemia. Circulation. 2007;116:2818-2829.
45. He T, Peterson TE, Katusic ZS. Paracrine mitogenic effect of human endothelial progenitor cells:role of interleukin-8. Am J Physiol Heart Circ Physiol. 2005;289:H968-H972.
46. Rüggeberg S, Horn P, Li X, Vajkoczy P, Franz T. Detection of a gamma-carboxy-glutamate as novel post-translational modification of human transthyretin. Protein Pept Lett. 2008;15:43-46.